Dr. Dale Nordenberg, MD
President, Medical Device Innovation, Safety, and Security Consortium and Co-CEO for Strategy, Novasano Health and Science
Dr. Nordenberg is a physician executive and medical epidemiologist with board certifications in pediatrics and medical informatics. Dr. Nordenberg’s career has focused on accelerating innovation at the intersection of technology and health sciences to optimize health and business outcomes. Dr. Nordenberg is the Founder and President for the Medical Device Innovation, Safety, and Security Consortium (MDISS) and is leading the development of the associated National Cyber Safety Network for Healthcare Technology. He co-chairs the Medical Device Security Information Sharing Council in the National Health Information Sharing and Analysis Center. He recently served as a member of the Health Information Technology Standards Federal Advisory Committee (ONC, HHS) and the FDA’s National Evaluation System for Technology Planning Board. Dr. Nordenberg is the co-founder and executive committee member of TBResist, a multinational genomics-based initiative to develop new diagnostics and therapeutics for drug resistant Tuberculosis now based at Boston Children’s Hospital, Harvard Medical School.
Dr. Nordenberg is also Founder and Co-CEO for Strategy for Novasano Health and Science, a company focused on optimizing medical device outcomes for patients, populations, and business. He led the Novasano team that built the technology platforms for multiple healthcare technology startup ventures. Previously, Dr. Nordenberg was a managing director in the health care practice of PwC; served as the Chief Information Officer (CIO) and Associate Director, National Center for Infectious Diseases (NCID) and as an advisor in the Office of the National Coordinator for Health Information Technology at HHS; was a member of the Science and Technology Review Subcommittee of the Science Advisory Board of the FDA, 2007 and 2009, and delivered Congressional testimony on the 2007 report; founded and Directed the Office of Medical Informatics at Egleston Children’s Hospital at Emory. Dr. Nordenberg was a founding executive of a company that launched VeriSign affiliates in Latin America and Asia; was a venture partner at Easton Capital; and is an adviser to early stage healthcare technology companies and venture firms. He is a fluent Mandarin speaker with many years of experience working with China-related ventures.
Dr. Nordenberg received a BS in Microbiology from the University of Michigan, his medical degree from Northwestern University, completed his training in pediatrics at McGill University, Montreal Children’s Hospital, and his fellowship in epidemiology and public health in the Epidemic Intelligence Services (EIS) Program at the Centers for Disease Control with a focus on ‘big data’.